68Ga-PSMA-11 PET/CT: the rising star of nuclear medicine in prostate cancer imaging?

Ever since the introduction of Ga-68-prostate-specific membrane antigen11 positron-emission tomography/computed tomography (Ga-68-PSMA-11 PET/CT) afew years ago, it has rapidly achieved great success in the field of prostate cancer imaging. Alarge number of studies have been published to date, indicating ahigh potential of Ga-68-PSMA-11 PET/CT in the work-up of prostate cancer patients, including primary diagnosis, staging and biochemical recurrence. The aim of this review is to present the most important data on this novel, highly promising imaging technique, and to formulate recommendations for possible applications of Ga-68-PSMA-11 PET/CT in clinical routine.